A detailed history of Vivo Capital, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 1,650,440 shares of SERA stock, worth $12.1 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
1,650,440
Previous 1,650,440 -0.0%
Holding current value
$12.1 Million
Previous $15 Million 34.95%
% of portfolio
1.44%
Previous 2.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$1.65 - $6.85 $339,192 - $1.41 Million
-205,571 Reduced 11.08%
1,650,440 $9.87 Million
Q3 2021

Nov 15, 2021

BUY
$7.9 - $13.04 $14.7 Million - $24.2 Million
1,856,011 New
1,856,011 $20.6 Million

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $218M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.